Caroline E. Porter

Also affiliated with Baylor College of Medicine, Methodist Hospital, Texas Children's Hospital

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors”.

Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors

Molecular Therapy(2020)10.1016/j.ymthe.2020.02.016

N/A

0DataRank · unranked

144 citations

Amanda Rosewell Shaw, Youngrock Jung, Tiffany Yip, Patricia Castro, Vlad C. Sandulache +6 more

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Communications Biology(2021)10.1038/s42003-021-01914-8

N/A

0DataRank · unranked

43 citations

Caroline E. Porter, Tiffany Yip, Way-Champ Mah, Mary K. McKenna, Matthew Dysthe +5 more

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

Science Advances(2023)10.1126/sciadv.ade6790

N/A

0DataRank · unranked

28 citations

Caroline E. Porter, Bora Lim, Amanda Rosewell Shaw, Catherine Robertson, Mae Woods +9 more

Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors

ImmunoHorizons(2024)10.4049/immunohorizons.2400059

N/A

0DataRank · unranked

7 citations

Emilie A. K. Warren, Kershena S. Liao, Hsuan‐Chen Liu, Chieko Michikawa, Caroline E. Porter +8 more

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009741

N/A

0DataRank · unranked

7 citations

Amanda Rosewell Shaw, Greyson Biegert, Caroline E. Porter, Mae Woods, Spyridoula Vasileiou +3 more

IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200899

N/A

0DataRank · unranked

3 citations

Daisuke Morita, Caroline E. Porter, Eric Tu, Greyson Biegert, Sonia Agrawal +4 more